Earnings summaries and quarterly performance for UNITEDHEALTH GROUP.
Executive leadership at UNITEDHEALTH GROUP.
Board of directors at UNITEDHEALTH GROUP.
Research analysts who have asked questions during UNITEDHEALTH GROUP earnings calls.
JL
Justin Lake
Wolfe Research, LLC
7 questions for UNH
Also covers: AGL, CI, CNC +8 more
LW
Lance Wilkes
Sanford C. Bernstein & Co., LLC
7 questions for UNH
Also covers: AGL, CI, CNC +4 more
LG
Lisa Gill
JPMorgan Chase & Co.
7 questions for UNH
Also covers: AGL, CAH, CI +13 more
Andrew Mok
Barclays
5 questions for UNH
Also covers: ACHC, ADUS, AGL +21 more
Joshua Raskin
Nephron Research
5 questions for UNH
Also covers: AIRS, BKD, CI +13 more
SF
Scott Fidel
Stephens Inc.
5 questions for UNH
Also covers: ACHC, ADUS, ALHC +17 more
AR
Albert Rice
UBS
4 questions for UNH
Also covers: ACHC, AMED, AMN +20 more
EW
Erin Wright
Morgan Stanley
4 questions for UNH
Also covers: ALGN, BTSG, CAH +18 more
Sarah James
Cantor Fitzgerald
4 questions for UNH
Also covers: ACHC, AMED, CI +15 more
Stephen Baxter
Wells Fargo & Company
4 questions for UNH
Also covers: AGL, BTSG, CAH +15 more
AR
A.J. Rice
UBS
3 questions for UNH
Also covers: BTSG, CYH, EHC +3 more
AH
Ann Hynes
Mizuho Financial Group
3 questions for UNH
Also covers: ARDT, BTSG, CI +17 more
DW
David Windley
Jefferies Financial Group Inc.
3 questions for UNH
Also covers: CERT, CNC, CRL +14 more
Jessica Tassan
Piper Sandler
3 questions for UNH
Also covers: ACCD, ALHC, AMWL +11 more
JG
Joanna Gajuk
Bank of America
3 questions for UNH
Also covers: ACHC, ADUS, AGL +21 more
KF
Kevin Fischbeck
Bank of America
3 questions for UNH
Also covers: AMN, ARDT, CCRN +9 more
Stephen Baxter
Wells Fargo
3 questions for UNH
Also covers: BTSG, CNC, CVS +6 more
Dave Windley
Jefferies LLC
2 questions for UNH
Also covers: CERT, CNC, ELV +7 more
George Hill
Deutsche Bank
2 questions for UNH
Also covers: AGL, CAH, CI +16 more
Josh Raskin
Nathron Research
2 questions for UNH
Also covers: CNC, MOH, PIII +1 more
Whit Mayo
Leerink Partners
2 questions for UNH
Also covers: ACHC, AHCO, ALHC +11 more
Benjamin Hendrix
RBC Capital Markets
1 question for UNH
Also covers: ACHC, ADUS, AHCO +25 more
MG
Matthew Gillmor
KeyCorp
1 question for UNH
Also covers: ACHC, ADUS, ALHC +11 more
Recent press releases and 8-K filings for UNH.
UnitedHealth Group faces Senate report over Medicare Advantage practices
UNH
Legal Proceedings
- A U.S. Senate Judiciary staff report found UnitedHealth Group used aggressive strategies, supported by enhanced staffing and AI, to capture diagnoses that raise Medicare Advantage payments.
- The findings add to longstanding allegations from watchdogs and whistleblowers that Advantage plans exaggerate patient illness, following a probe by Sen. Chuck Grassley after Wall Street Journal reporting.
- The report stops short of formal recommendations or allegations of legal wrongdoing, and UnitedHealth did not immediately comment.
- News of the report sent shares down 1.4%–3.1% in premarket trading, touching $339.42.
11 hours ago
UnitedHealth Group highlights Medicare Advantage value
UNH
- MA costs federal government 9% less than traditional Medicare in 2025, at $1,117 vs $1,234 per member per month, saving ~$117 monthly or over $1,400 annually.
- Managed care structure delivers $63 billion in additional annual value to enrollees through lower cost sharing, reduced premiums, and enhanced supplemental benefits.
- Average non-dual eligible aged-in MA-PD beneficiary spent 53% less ($3,651 vs $7,790) on total health care in 2025 compared to traditional Medicare with a PDP and Medigap Plan G.
- Phase-in of CMS’s V28 risk model led to a 4% reduction in MA revenue compared to the V24 model.
14 hours ago
UnitedHealth outlines audit-driven action plans amid DOJ probes
UNH
Legal Proceedings
Auditor Change
- After a profit shortfall, UnitedHealth launched independent audits and 23 action plans to boost automation and standardize processes; consultants found some “industry leading” operations, but FTI flagged documentation gaps in the HouseCalls program, with full results due early 2026
- CEO Stephen Hemsley initiated the reviews in May following Andrew Witty’s departure; UnitedHealth’s market value has fallen by $160 billion this year amid financial strains and DOJ civil and criminal probes
- The company expects about two-thirds of the action plans completed by end-2025 and full implementation by Q1 2026, overseen by its internal audit and advisory services team
- Executives attribute the profit shortfall to government reimbursement pressures and an unfavorable Optum Health patient mix; analysts suggest OptumRx could improve through enhanced audit practices and automation
Dec 19, 2025, 12:48 PM
UnitedHealth Group sells last South American unit Banmedica for $1B
UNH
M&A
Guidance Update
- UnitedHealth Group completed the sale of its last South American business, Banmedica, to Patria Investment for $1 billion, marking its full exit from the Latin American market.
- Banmedica serves 1.7 million health plan members across seven hospitals and 47 medical centers in Colombia and Chile.
- UnitedHealth recorded a $8.3 billion loss last year tied to its South American operations exit and holds a market capitalization of approximately $298.7 billion.
- The divestment is part of CEO Stephen Hemsley’s strategy to stabilize UnitedHealth, with management targeting a return to growth in 2026 and acceleration in 2027.
Nov 30, 2025, 6:27 PM
UnitedHealth Group appoints former FDA commissioner to board
UNH
Board Change
Hiring
- Dr. Scott Gottlieb, former FDA commissioner (2017–2019), joins UnitedHealth Group’s board effective November 18, 2025
- Gottlieb brings expertise in health policy, patient safety and pharmaceutical markets to support the company’s integrated healthcare strategy
- Appointment is part of a leadership overhaul amid a 36% stock price decline and follows the hiring of new CFO Wayne DeVeydt
- CEO Stephen J. Hemsley highlights Gottlieb’s role in advancing a technology-supported, integrated healthcare approach to bolster investor confidence
Nov 18, 2025, 12:53 PM
UnitedHealth Group reports Q3 2025 results
UNH
Earnings
Guidance Update
- Adjusted EPS of $2.92 on $113 billion revenue (+12% YoY); ended Q3 with >50 million domestic lives (YTD +780k) and 89.9% medical care ratio, 13.5% operating cost ratio, generating $5.9 billion cash flow; debt-to-capital at 44.1% after $3.4 billion Amedisys deal.
- Paused share buybacks and M&A, targeting debt-to-capital ~40% by H2 2026; anticipate reinstating capital returns later next year.
- UnitedHealthcare repriced risk businesses for 2026 margin growth, foresees ~1 million MA membership contraction to boost margins; Medicare margins breakeven in 2025, expected to decline further in 2026 absent funding changes.
- Optum Health refocusing on value-based care, narrowing networks and exiting ~200k PPO lives, aiming for just under 3% margin in 2025, with improvement in 2026 and targets of 6–8% by 2027; Optum Insight and Rx emphasize AI-first platforms and double-digit pharmacy growth.
- Announced low single-digit billion non-GAAP, largely non-cash charge for international and restructuring actions; full 2026 guidance to be provided with Q4 results in January.
Oct 28, 2025, 12:00 PM
UnitedHealth Group outlines Q3 2025 performance and 2026 outlook
UNH
Earnings
Guidance Update
New Projects/Investments
- UnitedHealth Group announced leadership and operational improvements, including repricing actions aimed at driving margin growth in 2026 and returning to double-digit earnings growth from 2027.
- UnitedHealthcare repriced most risk businesses, forecasting full-year 2025 Medicare Advantage medical cost trend of 7.5% and adopting a 10% trend assumption for 2026, with an expected 1 million member contraction in Medicare Advantage.
- Optum Health is refocusing on value-based care by narrowing networks and exiting 200 000 PPO lives, anticipating approximately 10% membership decline in 2026 before growth resumes.
- Optum Health’s margins are projected at just under 3% for 2025 with improvement in 2026; Optum Rx delivered double-digit revenue growth and has 85% of customers on full rebate pass-through arrangements.
- The CFO highlighted a $6 billion V28 headwind, accelerated investments in AI, Optum Health and Optum Insight, a return to normalized tax rates in 2026, debt reduction, and repricing tailwinds to support earnings recovery.
Oct 28, 2025, 12:00 PM
UnitedHealth Group reports Q3 2025 results and provides 2026 outlook
UNH
Earnings
Guidance Update
Product Launch
- UnitedHealth delivered Q3 adj. EPS of $2.92 and $113 B in revenue (+12% YoY), with a medical care ratio of 89.9% and investments of $450 M in employee incentives and philanthropy.
- UnitedHealthcare repriced most risk businesses for 2026, projects a Medicare Advantage medical cost trend of ~10%, expects ~1 M MA membership contraction, and aims for margin recovery by 2027.
- Optum Health is refocusing on value-based care, narrowing provider networks, exiting ~200 K lives, anticipating ~10% membership decline in 2026, and targeting long-term margins of 6–8%.
- CFO Wayne DeVeydt plans to reduce the debt-to-capital ratio to ~40% by H2 2026, pause share buybacks until then, and expects 2025 operating cash flow of ~$16 B, with formal 2026 guidance in January.
Oct 28, 2025, 12:00 PM
UnitedHealth Group raises 2025 profit forecast after Q3 beat
UNH
Earnings
Guidance Update
- Adjusted EPS of $2.92 in Q3 exceeded analyst estimates, signaling improved cost controls and a turnaround after prior challenges.
- Raised full-year 2025 adjusted EPS guidance to at least $16.25, above Wall Street expectations.
- Q3 net income fell to $2.35 billion from $6.05 billion a year ago due to higher costs in government-subsidized programs.
- Optum Rx revenue grew 16% to $39.7 billion, while Optum health services revenue was flat at $25.9 billion.
- Medical loss ratio remained at 89.9%, in line with forecasts, highlighting improved cost discipline but above target levels.
Oct 28, 2025, 10:03 AM
UnitedHealth Group reports Q3 2025 results
UNH
Earnings
Guidance Update
- UnitedHealth Group reported Q3 2025 consolidated revenues of $113.2 billion, up 12% year-over-year, with earnings from operations of $4.3 billion; GAAP EPS of $2.59 and adjusted EPS of $2.92
- The UnitedHealthcare segment saw revenues grow 16% to $87.1 billion, serving 50.1 million consumers, while Optum revenues rose 8% to $69.2 billion
- Operating cash flows were $5.9 billion (2.3x net income), and the debt-to-capital ratio was 44.1% as of September 30, 2025
- UnitedHealth Group raised its full-year 2025 EPS outlook to at least $14.90 (GAAP) and $16.25 (adjusted)
Oct 28, 2025, 10:02 AM
Fintool News
In-depth analysis and coverage of UNITEDHEALTH GROUP.
Quarterly earnings call transcripts for UNITEDHEALTH GROUP.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more